MRL/lpr |
Mutation of lpr gene that encodes Fas protein |
Diffuse lymphocytic infiltration of glands, presence of auto-antibodies (against ssDNA, RNPs, IgG), but no loss of secretion or detection of anti-M3R antibodies
Develop dacryoadenitis of the lacrimal glands and sialadenitis of the submandibular, parotid, and lingual glands
|
|
NOD |
Spontaneous insulitis and diabetes |
SjS-like disease phenotype with loss of secretion, anti-M3R antibodies, and focal lymphocytic infiltration |
|
NOD.B10-H2b
|
NOD with H2b from C57BL/10 |
SjS-like disease phenotypes without type I diabetes |
|
C57BL/6.NOD-Aec1Aec2
|
C57BL/6 mouse carrying Aec1 (Idd3) genetic region on Chr. 3 and Aec2 (Idd5) genetic region on Chr. 1 from NOD mouse |
SjS-like disease phenotypes
Increased expression of caspase, matrix metalloproteinase and PSP proteolytic enzymes, increased apoptosis, and altered protein secretions
Activated T/B cells, increased expression of pro-inflammatory cytokines, appearance of autoantibodies and loss of secretory function
|
|
(NZB/NZW) F1 |
Naturally occurring mouse model by crossing NZB and NZW |
Lacrimal gland involvement that shows greater percentage of B cells compared with MRL/lpr mouse |
|
NFS/sld
|
Autosomal recessive gene with sublingual gland differentiation arrest |
Anti-α-fodrin antibodies |
|
Id3 gene knock-out (KO) |
No Id3 (basic helix-loop-helix transcription factor) production, a dominant negative inhibitor of gene expression |
Impaired TCR-mediated T-cell selection, loss of secretion and presence of anti-Ro and anti-La antibodies |
|
Aromatase gene KO |
Estrogen deficient due to absence of enzyme catalyzing the conversion of testosterone to estradiol |
B cell hyperplasia in the BM and spleen and anti-α-fodrin antibodies |
|
Baff gene knock-in |
Over-expression of the B-cell survival factor, BAFF (BLys) |
Lymphocytic infiltration with a majority of B cells, leading to loss of secretion by 15–17 months of age |
|
IQI/Jic |
Inbred strain originating from ICR with SjS-like disease in the absence of diabetes |
Anti-kallikrein-1 and -13 antibodies |